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miR-379 deletion ameliorates features of diabetic
kidney disease by enhancing adaptive mitophagy
via FIS1
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Diabetic kidney disease (DKD) is a major complication of diabetes. Expression of members of
the microRNA (miRNA) miR-379 cluster is increased in DKD. miR-379, the most upstream
5′-miRNA in the cluster, functions in endoplasmic reticulum (ER) stress by targeting EDEM3.
However, the in vivo functions of miR-379 remain unclear. We created miR-379 knockout
(KO) mice using CRISPR-Cas9 nickase and dual guide RNA technique and characterized their
phenotype in diabetes. We screened for miR-379 targets in renal mesangial cells fromWT vs.
miR-379KO mice using AGO2-immunopreciptation and CLASH (cross-linking, ligation,
sequencing hybrids) and identified the redox protein thioredoxin and mitochondrial fission-1
protein. miR-379KO mice were protected from features of DKD as well as body weight loss
associated with mitochondrial dysfunction, ER- and oxidative stress. These results reveal a
role for miR-379 in DKD and metabolic processes via reducing adaptive mitophagy. Strate-
gies targeting miR-379 could offer therapeutic options for DKD.
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Both type 1 and type 2 diabetes (T1D and T2D) areassociated with significantly accelerated complications,including renal disease, known as diabetic kidney disease
(DKD)1–5. To date, there are very few effective drugs for DKD
and affected individuals often succumb to end-stage renal disease
needing dialysis or renal replacement, underscoring the urgent
need to explore better drug targets. Key features of DKD include
renal fibrosis and hypertrophy due to accumulation of extra-
cellular matrix (ECM) proteins such as collagens and fibronectin
in renal glomerular and tubular compartments, as well as albu-
minuria and podocyte dysfunction1–5. Metabolic alterations,
including mitochondrial dysfunction and oxidative stress, in most
renal cells, including tubular epithelial, glomerular mesangial and
podocytes, are associated with progressive DKD3,5,6.
Non-coding RNAs such as microRNAs (miRNAs) and long-
non-coding RNAs (lncRNAs) regulate gene expression via post-
transcriptional and epigenetic mechanisms. miRNAs are short
non-coding RNAs that target about 60% of the genome and alter
gene expression by base-pairing with complementary “seed”
sequences in the 3′-untranslated region (3′-UTR) of their target
genes7. lncRNAs are longer transcripts such as messenger RNAs
(mRNAs) but lack protein-coding (translation) potential8,9.
miRNAs and lncRNAs regulate cellular functions and patho-
physiological conditions associated with human disease including
kidney dysfunction and DKD3,10. We and others have used
in vitro mechanistic and in vivo models to describe the functional
roles and actions of several miRNAs, e.g., miR-192, miR-21, miR-
93, miR-200, miR-29, as well as various lncRNAs in the patho-
genesis of DKD, and also evaluated the translation potential of
targeting them as treatment options for DKD3,10–12.
We recently established that a megacluster of miRNAs
(including miR-379 and others), along with its host lncRNA
(lncMGC), is upregulated via endoplasmic reticulum (ER) stress
in the kidneys of diabetic mice and induces early features of DKD
such as hypertrophy and fibrosis13. To inhibit lncMGC, we
designed a GapmeR (locked nucleic acid and phosphorothioate-
modified antisense oligonucleotide), which efficiently inhibited
expression of the miR-379 cluster and lncMGC, and attenuated
features of early DKD in mice13. We also showed that miR-379,
the first miRNA (5′-end) in the megacluster, targets and down-
regulates the ER degradation enhancer, mannosidase α-like 3
(EDEM3)13,14, in glomerular mesangial cells, suggesting it may
have metabolic functions in the kidney.
We designed the present study to delineate the in vivo func-
tional role of miR-379 in the kidney under diabetic conditions
and the putative DKD-related functions of its targets. Transgenic
and genetic knockout (KO) mutant mice provide useful models
for studying diabetes and diabetic complications. Generation of
mutant mice has become much faster and more efficient with the
CRISPR-Cas9 editing method. We therefore created miR-379KO
mice using the CRISPR-Cas9 nickase technique15. Although
miRNA targets are typically predicted by matching seed
sequences and flanking sequences using in silico techniques7,16,17,
additional targets have recently been identified more reliably by
experimental methods that examine direct interaction of miRNAs
and target RNAs in living cells using a strategy that combines
immunoprecipitation (IP) of components of the RNA-induced
silencing complex [RISC; e.g., argonaute (AGO) proteins], liga-
tion of AGO-associated RNA–RNA duplexes to form chimeric
RNAs, and subsequent RNA sequencing (RNA-seq)18–20. As
analysis of data from such CLASH (cross-linking, ligation, and
sequencing of hybrids) method does not rely on bioinformatics
prediction algorithms, the miRNA targets identified in this
unbiased manner from AGO-IP can be further evaluated as
therapeutic targets for various human diseases, including DKD.
In this study, we identified new miR-379 targets related to
oxidative stress, ER stress, and mitochondrial dysfunction using
the unbiased AGO2-CLASH technique19 by comparing mouse
glomerular mesangial cells (MMCs) isolated from wild-type (WT)
and miR-379KO mice. We validated the expression of these new
targets in vivo using WT and miR-379KO mice. MMC from miR-
379KO mice depicted protection from high-glucose (HG)-
induced metabolic and mitochondrial dysfunction through
enhanced adaptive mitophagy. Importantly, we showed that, in a
streptozotocin (STZ)-injected model of T1D, miR-379KO mice
were protected from key features of DKD, including renal dys-
function, glomerular expansion, renal fibrosis, and glomerular
basement membrane (GBM) thickening, compared to corre-
sponding diabetic WT mice.
Results
Generation of miR-379KO mice by CRISPR-Cas9 genome
editing. Figure 1a shows the schematic genome structure of the
mouse lncMGC region which hosts the miR-379 megacluster, in
which miR-379 is the most 5′-miRNA within the cluster and
miR-882 is outside. For CRISPR-Cas9-mediated generation of
miR-379KO in mice, we designed guide RNAs as described in the
“Methods.” The guide RNAs (Fig. 1b) were first verified for
cleavage activity in vitro using the TCMK1 mouse kidney cell line
(see “Methods”). We then created miR-379KO mice by injecting
fertilized eggs from C57BL/6J mice with guide RNAs and RNA
encoding CRISPR-Cas9 nickase. We sequenced the PCR frag-
ments from mouse genomic DNA samples to confirm that several
surviving mice showed the 36 bp deletion of the miR-379 region
(Fig. 1c). We crossed the third generation of these founder mice
with WT C57BL/6J mice and obtained homozygous miR-379KO
mice (homozygotes, −/−) by intercrossing germline-transmitted
heterozygous mice (heterozygotes, +/−) (Fig. 1c). We confirmed
significant reduction of miR-379 in glomeruli isolated from kid-
neys of miR-379KO mice compared to WT mice (Fig. 1d, P <
0.0001). The miR-379KO mice appeared normal and did not
depict any overt defects or abnormalities.
AGO2-IP-CLASH screening identifies novel targets of miR-
379. The AGO-CLASH technique allows unbiased high-
throughput identification of miRNA targets by ligation and
sequencing of miRNA-target RNA duplexes associated with
AGO2 protein, a key component of the RISC complex. We per-
formed AGO2-CLASH as described19,20 (see “Methods” and
Supplementary Fig. 1) using MMC isolated from WT and miR-
379KO mice. We also immunoprecipitated the AGO2 RISC
complex with anti-mouse AGO2 beads. After phosphorylation of
the RNA 5′-ends and ligation using T4 RNA ligase, we extracted
the ligated RNAs and subjected them to RNA-seq. To identify
bona fide targets of miR-379, we compared RNA-seq data from
total RNAs, AGO2-IP RNAs, and AGO2-IP-CLASH RNAs
between WT and miR-379KO MMCs (Supplementary Fig. 1).
From data analyses, we found several promising candidate targets
of miR-379 (i.e., reads highly enriched at their respective 3′-UTRs
in WT cells but decreased in miR-379KO cells). One of these was
Fis1, because we identified sequences at the 3′-UTR of Fis1, which
hybridized with miR-379 following AGO2-IP in WT but not in
miR-379KO MMC (Fig. 2a and Supplementary Table 1). We
observed extensive sequence complementarity between miR-379
and the Fis1 3′-UTR (Fig. 2b). We also detected significant
enrichment of RNA-seq reads at the Fis1 3′-UTR following
AGO2-IP in WT but not miR-379KO MMC (Fig. 2c). We con-
firmed the absence of miR-379 following AGO2-IP in miR-
379KO MMC using quantitative PCR (qPCR) (Fig. 2d) and,
conversely, we observed a significant increase in Fis1 gene
expression in miR-379KO MMC compared to WT MMC
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(Fig. 2e), suggesting Fis1 is a bona fide target of miR-379. This
was of interest, because FIS1 is a key mitochondrial protein21,22.
We next performed luciferase reporter assays using a psiCheck2
vector in which we cloned the 3′-UTR of Fis1, which demon-
strated that Fis1 3′-UTR luciferase activity was significantly
decreased in MMCs treated with miR-379 mimic oligonucleotides
(oligos) compared to negative control (NC) oligos in WT MMC
(Fig. 2f). This decrease was not observed in cells transfected with
the Fis1 3′-UTR vector harboring a mutation in the miR-379
binding site, further confirming Fis1 to be a target of miR-379
(Fig. 2f).
From comparisons of AGO2-IP RNAs, besides Fis1 (Fig. 2c)
encoding the mitochondrial fission protein FIS122–24, we also
examined other candidate targets of miR-379 with putative
functions related to kidney disease. We confirmed Edem3 as a
target, which we previously identified13, and also identified
interesting new candidate miR-379 target genes, including those
encoding the redox protein Txn1 (Fig. 2g), the growth factor
Vegfb, the transporter protein Slc20a1, the RNA-binding protein
Hnrnpc, the clathrin protein Clta, and the adapter protein Ap3s1
(Supplementary Fig. 2a–e and Supplementary Table 2a, b).
Interestingly, Ingenuity pathway analyses (IPAs) of the RNA-
seq data revealed pathways related to mitochondrial function
(mitochondrial depolarization, transition, and permeability of
mitochondria), as well as renal injury (renal ischemia, acute renal
failure, glomerular injury, hypertrophy) were enriched in the
differentially expressed genes between WT and miR-379KO
MMC (Supplementary Fig. 3a, b). These data suggest that the
targets of miR-379 are involved in processes related to
mitochondrial and renal function.
We further validated Txn1, because it encodes a redox protein,
thioredoxin, and we also detected significant enrichment of RNA-
seq reads at the Txn1 3′-UTR following AGO2-IP in WT but not
miR-379KO MMC (Fig. 2g). We again performed luciferase
reporter assays using a psiCheck2 vector harboring the Txn1 3′-
UTR, which showed that Txn1 3′-UTR luciferase activity was
significantly decreased by miR-379 mimic oligos compared to NC
in WT MMC. In contrast, we detected no change in cells
transfected with a miR-379-binding site mutant Txn1 3′-UTR
reporter luciferase vector, further confirming that Txn1 is a real
target of miR-379 (Fig. 2h). We also further validated the RNA-
seq data from AGO2-IP RNAs by performing qPCR validations,
which confirmed the significant decrease in enrichments of
Edem3, Fis1, Txn1, Clta, Vegfβ, Ap3s1, and Hnrnpc, but not
Slc20a1 or NCs, in AGO2-IP from miR-379KO MMC compared
to WT (Fig. 2i), verifying they are valid targets of miR-379.
Among these, EDEM3 has a key role in regulating ER stress14,
FIS1 functions in mitochondrial fission and quality control,
including mitophagy22,25, and TXN1 has several roles, including
antioxidant functions, all factors related to DKD26. Therefore,
increased ER stress, mitochondrial dysfunction, and oxidative





























































Fig. 1 Generation of miR-379 knockout (KO) mice by CRISPR-Cas9 editing. a Schematic genomic location of the miR-379 megacluster (MGC) of miRNAs
(miR-379-3072) and structure of wild-type (WT) and miR-379 knockout (KO) mice. The miR-379 MGC is located on mouse chromosome 12 within the
host lncRNA (lncMGC) and consists of ~40 miRNAs. miR-379 is the most 5′-miRNA, miR-495, miR-377, and miR-3072 are in the middle, and miR-882 is
located far upstream of cluster. b Sequences of miR-379 genomic regions WT (upper) and KO (lower, 36 bp deletion). Positions of guide RNAs used for
editing by CRISPR-Cas9 approach are shown by arrows. Sequences of mature miR-379 are represented in blue and the precursor miR-379 in pink. PAM
sequences (NGG) are underlined. c Left, genotypes of WT and a founder (31F) mouse from tail DNA samples. The founder [31F (+/−), left panel] shows a
36 bp shorter PCR fragment (i.e., deletion of miR-379). Lane M: molecular weight markers. Right, germline transmission of miR-379 deletion. The female
founder heterozygote (31F+/−) was crossed with a WT male and the deletion was transmitted to the next generation; multiple heterozygotes (+/−), WT,
and/or miR-379 deletion are shown. Homozygotes (−/−, miR-379 deletion) were obtained by crossing heterozygous mice. The miR-379KO mouse colony
was expanded by crossing the homozygous mice. d Significant decrease of glomerular miR-379 RNA expression in miR-379KO mice compared to WT mice
(n= 5–6/group). Statistical analyses for two groups were performed by Student’s t-test. Data are presented as mean ± SEM.
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Fig. 2 Identification of miR-379 targets. a Example of hybrid sequence of miR-379 in pink and Fis1 in blue. b Alignment of miR-379 and its target site in the
Fis1 3′-UTR (miRanda; microRNA.org). c Enrichment of AGO2 IP-seq RNA reads at miR-379 target site in Fis1 3′-UTR in WT mouse mesangial cells
(MMC), with notable reduction in miR-379KO MMC. Two independent samples (A and B) from WT MMC (WT-A-IP and WT-B-IP) and miR-379KO
MMC (379KO-A-IP and, 379KO-B-IP) were examined. d Enrichment of miR-379 RNA in AGO-IP in MMC isolated from kidney glomeruli of WT mice and
significant reduction in miR-379KO MMC (n= 3/group). e Significant increase of Fis1 gene expression in miR-379KO MMC compared to WT MMC,
suggesting Fis1 is a target of miR-379 (n= 6/group). f Significant decrease of WT Fis1 3′-UTR luciferase reporter activity by transfection with miR-379
mimic oligonucleotide, compared to mutant Fis1 3′-UTR reporter under similar conditions, further supporting Fis1 3′-UTR to a true target of miR-379.
g Enrichment of AGO2 IP-seq RNA reads at the 3′-UTR of Txn1 gene in WT MMC and its significant reduction in miR-379KO MMC. Two independent
samples (A and B) from WT MMC (WT-A-IP and WT-B-IP) and miR-379KO MMC (379KO-A-IP and 379KO-B-IP) were examined. h Significant decrease
of WT Txn1 3′-UTR luciferase reporter activity induced by miR-379 mimics, compared with no change in mutant Txn1 3′-UTR reporter by miR-379 mimics.
NC, negative control mimic; miR-379, miR-379 mimic. i RT-qPCR validation of the expression of enriched candidate genes identified by AGO2 IP-seq. RNA
expression of all eight candidate miR-379 targets tested was decreased in AGO2-IP from miR-379KO MMC compared to WT MMC. Rab14, Snrpe, Tcea1,
and Hmgb1 were used as negative controls because their enrichments in AGO2 IP-seq were not significantly changed between miR-379KO and WT MMC.
Each dot indicates one biological repeat. Statistical analyses for two groups were performed by Student’s t-test, and for multiple comparisons one-way
ANOVA with Tukey’s post hoc test was used. *P < 0.05, **P < 0.01. All data are presented as mean ± SEM.
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genes Edem3, Fis1, and Txn1, respectively, may significantly
contribute to DKD.
miR-379KO MMC are protected from HG-induced mito-
chondrial dysfunction. As we identified the mitochondrial pro-
tein FIS1 as a miR-379 target, we compared mitochondrial
function between WT and miR-379KO MMC using a Seahorse
XF Cell Mito Stress test. In WT MMC treated with HG (25 mM),
we observed a significant decrease in oxygen consumption rate
(OCR) at basal respiration, ATP production rate, and maximal
respiration compared to WT MMC treated with normal glucose
(NG; 5.5 mM) (Fig. 3a, b). Interestingly, miR-379KO MMCs were
significantly protected from this HG-induced decrease of mito-
chondrial function.
As we previously showed miR-379 is upregulated by HG in
MMC13, we next tested whether HG treatment reduces levels of
the miR-379 target, namely the mitochondrial protein FIS1 and
whether a loss of FIS1 (by HG or Fis1 siRNA treatment) affects
mitochondrial quality and health. We transfected WT MMC with
siRNA-targeting Fis1 (si-Fis1) and verified reduction in FIS1
protein levels by immunohistochemical (IHC) staining relative to
NC siRNA (Fig. 3c). Significant reduction of FIS1 by the Fis1
siRNA was observed in both WT and miR-379KO MMC (Fig. 3c,
d, si-Fis1). We found that FIS1 expression was also significantly
decreased in WT MMC treated with HG (Fig. 3c, d, WT MMC),
further supporting Fis1 as a target of miR-379 and this is in line
with our earlier data showing miR-379 is upregulated by HG13. On
the other hand, no significant decrease of FIS1 was detected in
miR-379KO MMC treated with HG (miR-379KO HG-NC), as
compared to WTMMC HG-NC vs. the respective NG-treated cells
(Fig. 3c, d). These results are consistent with the Seahorse results
showing that mitochondrial activity is maintained at higher levels
in miR-379KO MMC even under HG conditions (Fig. 3a, b).
To strengthen the results in Fig. 3a, b demonstrating the effects











































































































Fig. 3 Mitochondrial function assays in MMC under normal and high-glucose conditions. a Seahorse XF Cell Mito Stress test for mitochondrial function
at basal conditions, ATP production, and maximal respiration levels using MMC from WT or miR-379KO mice cultured with normal glucose (NG, 5.5 mM)
or high glucose (HG, 25mM) for 72 h. b Oxygen consumption rates (OCRs) were calculated in basal and spare respiratory capacity (SRC) levels in NG and
HG condition (20,000 cells per well of 96-well assay plate). c Representative images of IHC staining to detect FIS1 expression (brown color) in negative
control (NC) and Fis1 siRNA (si-Fis1)-transfected MMC from WT or miR-379KO mice cultured with NG or HG. d Bar graph quantifications showing
significant reduction in FIS1 levels in si-Fis1-transfected NG- or HG-treated WT and miR-379KO MMC compared to NC, and significant decrease in FIS1
levels in HG-treated WT MMC but not miR-379KO MMC (n= 15 cells/group). The in vitro experiments were performed with at least three biological
replicates. One-way ANOVA with Tukey’s post hoc test for multiple comparisons. **P < 0.01, ****P < 0.0001. All data are presented as mean ± SEM. NC,
negative control siRNA. si-Fis1, Fis1 siRNA.
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transfected WT and miR-379KO MMC with the DsRed2-Mito-7
plasmid, which fluorescently labels mitochondria with red
emission spectra (Fig. 4a and quantification in Fig. 4c). The
MMC were also transfected with a NC siRNA or si-Fis1. Under
HG conditions, mitochondrial signal intensity was significantly
reduced compared to NG conditions in both WT-MMC and
miR-379KO MMC. However, the degree of reduction of
mitochondrial signal intensity was much lesser in miR-379KO
MMC (Fig. 4a, NC, upper panel, and Fig. 4c). Moreover, although
Fis1 siRNA reduced mitochondrial signal intensity significantly in
WT MMC in NG and HG, Fis1 siRNA elicited more significant
changes in miR-379KO MMC in HG than in NG (Fig. 4a, si-Fis1
lower panel, and Fig. 4c). These results demonstrate that a
combination of HG and si-Fis1 promotes more mitochondrial
dysfunction in miR-379KO MMC, unlike in WT MMC, and
further support the notion that miR-379-mediated loss of Fis1
promotes mitochondrial dysfunction.
Increasing evidence shows that, although FIS1 is a mitochon-
drial fission protein, FIS1 can promote adaptive mitophagy to
clear damaged mitochondria and is thus important for preserving
mitochondrial function and health23,24,27. As miR-379 deficiency
improved mitochondrial function in MMC and, conversely,
siRNA-induced reduction of its mitophagy-related target Fis1
appeared to worsen mitochondrial function, we next examined
whether MMC from miR-379KO mice display better mitochon-
drial quality and health through adaptive mitophagy under
diabetic conditions, compared to WT. Tandem fluorescent-tagged
inner mitochondrial membrane protein COX8 (Cox8-GFP-
mCherry) reporter monitors mitophagy-based on different pH
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fluorescent proteins23,27. Under steady normal states, cells depict
yellow signals in mitochondrial regions, i.e., red (mCherry) plus
green (GFP) fluorescence. Under conditions triggering mito-
phagy, mitochondria are delivered to acidic lysosomes (adaptive
mitophagy) where GFP signal is reduced due to its sensitivity to
the acidic environment, but mCherry fluorescence remains stable.
To monitor the role of Fis1 in adaptive mitophagy (to clear
damaged mitochondria), WT and miR-379KO MMC that were
again transfected with either a NC siRNA or Fis1 siRNA were
transfected with the pCLBW-Cox8-EGFP-mCherry (reporter for
mitophagy) and treated with HG (25 mM) or NG (5.5 mM) for
5 days and monitored on day 5. Upper panel in Fig. 4b (NC) and
bar graph quantification in Fig. 4d show that, relative to NG
conditions, adaptive mitophagy (red fluorescence) was signifi-
cantly decreased in WT-MMC after 5 days of HG treatment.
However, no significant decrease of mitophagy was detected in
the miR-379KO MMC treated with HG vs. NG (Fig. 4b, NC,
upper panel, and quantification in Fig. 4d). The lower panel of
Fig. 4b (si-Fis1) and quantification in Fig. 4d show that, although
Fis1 siRNA significantly reduced mitophagy in WT MMC in both
NG and HG (vs. corresponding NC siRNA), no significant
changes were detected in miR-379KO MMC with si-Fis1 vs. NC
siRNA (maintaining high levels of mitophagy). Thus, mitophagy
was significantly reduced in WT MMC under HG conditions vs.
NG with or without Fis1 siRNA. On the other hand, adaptive
mitophagy was reduced only in miR-379KO MMC treated with
Fis1 siRNA in HG conditions but not in NG conditions,
demonstrating that only a combination of Fis1 siRNA and HG
reduces adaptive mitophagy in miR-379KO MMC (Fig. 4b, d).
Thus, miR-379KO MMC are more resistant to HG treatment
than WT MMC and maintain good quality of mitochondria.
Together, these results suggest that adaptive mitophagy is
regulated through Fis1 targeted by miR-379 in MMC, and that
reduction of adaptive mitophagy due to increased miR-379 in
diabetes leads to reduced mitochondrial quality and contributes
to mitochondrial dysfunction.
In addition to these parameters of mitophagy and mitochon-
drial quality/function, we also measured some parameters of
autophagy, which is associated with mitophagy. We measured
protein expression of ATG5 and P62 (autophagy-related
proteins) in mouse kidney glomeruli using IHC staining
(Supplementary Fig. 4). ATG5 levels were significantly lower in
glomeruli from diabetic WT mice compared to nondiabetic WT
mice, whereas no significant changes were observed in miR-
379KO mice (diabetic vs. nondiabetic). P62 levels were
significantly higher in glomeruli from diabetic WT mice
compared to nondiabetic WT mice, but these differences were
not observed in diabetic miR-379KO mice vs. corresponding
nondiabetic miR-379KO mice.
Taken together, these results indicate that autophagy and
related adaptive mitophagy are decreased in MMC from diabetic
WT mice relative to diabetic miR-379KO mice. Increased miR-
379 under diabetic conditions may promote mitochondrial
dysfunction, at least in part by the reduction of its newly
identified target Fis1.
miR-379KO mice are protected from diabetes-induced weight
loss. To next characterize the in vivo role of miR-379 in diabetes,
we used STZ injections to induce insulin-dependent diabetes in
male WT and miR-379KO mice according to protocols of the
NIDDK DiaComp consortium28 (Supplementary Fig. 5), and
then measured various metabolic parameters of diabetes at 1, 6,
and 24 weeks after diabetes onset (Fig. 5). Male mice were used
because female mice do not consistently develop diabetes with the
multiple low dose STZ injection protocol used29,30. Blood glucose
levels were monitored and measured at regular intervals (Sup-
plementary Fig. 5b) and mice were killed at 1, 6, or 24 weeks post
diabetes. There was no significant difference in the incidence of
diabetes between WT and miR-379KO mice. Non-fasting blood
glucose levels were significantly higher at individual time points
in both WT and miR-379KO diabetic mice compared to their
respective nondiabetic controls (Fig. 5a). The average body weight
over the period of 24 weeks of diabetes was significantly lower in
WT-STZ mice compared to WT nondiabetic controls (Fig. 5b).
On the other hand, despite persistent hyperglycemia, body weight
loss observed in the WT-STZ mice was significantly ameliorated
in miR-379KO-STZ mice, their weights being significantly higher
compared to WT-STZ mice at 1, 6, and 24 weeks (Fig. 5b). We
performed body composition analysis, which showed that both
total body fat and lean mass were significantly reduced over time
in WT-STZ mice compared to nondiabetic controls; in contrast,
miR-379KO-STZ mice did not display significant reduction in
body fat and lean mass (Fig. 5c, d). This protection from diabetes-
induced loss of muscle mass in the miR-379KO-STZ mice sug-
gests a key role of miR-379 also in diabetes-induced muscle
atrophy.
We next measured metabolic parameters (food, water intake,
and movement) and found that they were not significantly
different between WT and miR-379KO mice (Supplementary
Fig. 6a–c), suggesting that weight loss in WT-STZ mice may not
be because of any altered behavior (eating, drinking, or moving).
Fig. 4 Mitochondrial dysfunction and mitophagy assays in MMC under normal and high-glucose conditions. a Representative images of WT and miR-
379KO MMC transfected with the DsRed2-Mito-7 plasmid, which fluorescently labels mitochondria with red emission spectra (quantification in c). WT
and miR-379KO MMC treated with NC siRNA or Fis1 siRNA were transfected with DsRed2-Mito-7 reporter. Upper panel (with NC siRNA): in HG
conditions (25mM glucose), mitochondrial signal intensity (red fluorescence) was significantly reduced compared to NG (5.5 mM glucose) conditions in
both WT and miR-379KO MMC, but to a lesser extent in miR-379KO MMC. Lower panel: with si-Fis1: WT-MMC cells treated with si-Fis1 show decreased
intensity in mitochondrial fluorescent signals in NG and HG conditions. miR-379KO MMC with si-Fis1 under HG conditions depicted more significant
changes than under NG conditions. The degree of reduction of fluorescence (mitochondrial quality) under HG conditions was much lower in miR-379KO
MMC compared to WT MMC. b Representative images showing adaptive mitophagy in MMC examined by expressing the pCLBW-cox8-EGFP-mCherry
reporter (quantification in d). WT and miR-379KO MMC MMC treated with NC siRNA or Fis1 siRNA were transfected with pCLBW-cox8-EGFP-mCherry
and then treated with HG (25mM) or NG (5.5 mM) for 5 days at 37 °C and 5% CO2. Upper panels (with NC siRNA): adaptive mitophagy shows marked
decrease in WT-MMC after 5 days of HG treatment (decrease in red mCherry fluorescence) but not in NG; lower panels (with si-Fis1): Fis1 siRNA
significantly reduced mitophagy in WT MMC in NG and HG conditions, but no significant changes were detected in miR-379KO MMC even under HG
conditions. Adaptive mitophagy was significantly reduced only in miR-379KO MMC treated with Fis1 siRNA in HG conditions relative to NC under NG
conditions. c Bar graph quantification of DsRed2-Mito-7 staining data (shown in a) based on analysis of integrated density (n= 6 cells/group). d Bar graph
of quantitative analysis of the number of red-only puncta per cell from data in b (n= 3–8 cells/group). These in vitro experiments in MMC were performed
with at least three biological replicates. One-way ANOVA with Tukey’s post hoc tests for multiple comparisons in panels c and d. *P < 0.05, **P < 0.01,
****P < 0.0001. All data are presented as mean ± SEM. NC, negative control siRNA. si-Fis1, Fis1 siRNA. Scale bar, 50 µm.
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There were also no significant differences in oxygen consumption
(VO2) or CO2 production (VCO2) (Supplementary Fig. 6d, e). We
measured respiratory exchange rates (RERs) to determine the fuel
source in all the four groups of mice, which indicated that fat is
the pre-dominant fuel source in both diabetic WT and miR-
379KO mice, as they had lower RER compared to their
nondiabetic controls (Supplementary Fig. 6f). However, there
were no differences between WT and KO mice. Altogether, these
data suggest that miR-379 may contribute to metabolic
abnormalities, because miR-379KO mice were protected from
body weight loss and muscle atrophy in diabetes.
miR-379KO mice are protected from diabetes-associated
albuminuria. As the targets of miR-379 have potential reno-
protective properties, we next examined whether miR-379KO
mice exhibit renal protection in diabetes. To examine the effects
of miR-379 loss on kidney function, we measured albumin and
creatinine levels in 24 h urine samples collected from control and
STZ-injected diabetic WT and miR-379KO mice at 6 and
24 weeks after diabetes onset. Increased albumin excretion is
widely considered to reflect underlying glomerular dysfunction in
diabetic mice; measures of the albumin/creatinine ratio (ACR)
control for variations in urine flow. At 6 weeks post diabetes
induction, there were no differences in albuminuria or creatinine
levels among any groups of mice, as expected in this C57BL6
mouse model. However, at 24 weeks post diabetes induction,
average urine albumin levels were significantly increased in WT-
STZ mice compared to nondiabetic controls and this was
significantly attenuated in miR-379KO-STZ mice (Fig. 5e).
Consistent with this, at 24 weeks, ACR was ~8-fold higher in
WT-STZ mice than in nondiabetic controls and this increase was
significantly attenuated in miR-379KO-STZ mice compared to
WT-STZ mice (Fig. 5f).
miR-379KO mice are protected from diabetes-induced glo-
merular hypertrophy and ECM accumulation. Glomerular
lesions and early glomerular hypertrophy are among the most
significant alterations in both early and late stages of DKD. As
miR-379KO mice were protected from diabetes-induced albu-
minuria, to further define the relationship to renal histology, we
prepared kidney cortical sections from STZ-injected and control-
vehicle injected WT and miR-379KO mice. We used Periodic
Acid–Schiff (PAS) staining to detect ECM accumulation and
Masson’s Trichrome staining to assess kidney fibrosis. WT-STZ
mice showed significant increase in mesangial matrix expansion
compared to nondiabetic controls at 6 and 24 weeks of diabetes
onset (Fig. 6a, b). Moderate glomerular tuft and tubulointerstitial
fibrosis were observed in WT-STZ mice after 24 weeks of diabetes
onset (Fig. 6c). Notably, all these increases related to DKD were
ameliorated in miR-379KO-STZ mice (Fig. 6a–c). These results
show that diabetic miR-379KO-STZ mice experience reduced
severity in key features of early DKD, suggesting miR-379KO
mice are protected from DKD.
miR-379KO mice are protected from diabetes-associated GBM














































































































Fig. 5 Physiological parameters of diabetic and nondiabetic mice. a Diabetes was induced in WT and miR-379KO mice by STZ injections as described in
the “Methods.” Non-fasting blood glucose levels (BGL) in WT and miR-379KO mice at indicated time periods during 24 weeks after diabetes onset
compared to control (Con) (n= 5/group). b–d, Body weights and body composition analysis using Echo/MRI system. b Body weight (n= 8/group, n=
6–9/group, and n= 5–6/group for 1, 6, and 24 weeks post diabetes onset, respectively). c Total body fat (n= 8 and n= 4 for 1 and 6 weeks of diabetes,
respectively). d Total lean mass (n= 4 for 6 weeks of diabetes). e, f Kidney function (urine albumin excretion) was examined using ELISA in 24 h urine
collections after 24 weeks of diabetes. e Urine albumin level (n= 4–5/group). f Albumin/creatinine ratio (ACR) (n= 4–5/group). Each dot indicates the
value from each mouse. One-way ANOVA with post hoc Tukey’s test for multiple comparisons. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. All data
are presented as mean ± SEM.
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transmission electron microscopy (TEM) to examine glomerular
structure in STZ- and control-treated WT and miR-379KO mice
at 24 weeks after diabetes onset. Nondiabetic WT controls
showed uniformly thin GBMs and normal structures of podo-
cytes, and their foot processes; in contrast, WT-STZ mice
exhibited thickening of the GBM and podocyte foot process
effacement as expected (Fig. 6d). Nondiabetic miR-379KO mice
also exhibited normal glomerular structures that were like WT
control mice. However, the GBM thickening and podocyte foot
process effacement observed in WT-STZ mice were abrogated in
miR-379KO-STZ mice (Fig. 6d). Quantitative analysis confirmed
that the GBM was significantly thinner in miR-379KO-STZ mice
than in WT-STZ mice (Fig. 6e). Furthermore, WT-STZ mice
developed excessive mesangial expansion with electron-dense
WT miR-379KO
























c                           
d                           
f                            
g                            
i                            















































































Con STZ Con STZ
WT miR-379KO
j                           
b                            
e                            

































Fig. 6 Histological evaluation of kidney cortex samples fromWT and miR-379KO mice (control and diabetic). a PAS (Periodic acid–Schiff stain) staining
in control mice and diabetic mice at 6 and 24 weeks after diabetes onset. Representative images show glomerular mesangial area and extracellular matrix
(ECM) accumulation. b Quantitative analysis of PAS-positive glomerular areas at 6 and 24 weeks post diabetes induction (n= 30 glomeruli/group).
c Masson’s trichrome staining to detect fibrosis in WT and miR-379KO mice 24 weeks after diabetes onset. Representative images show fibrosis (blue
color) in WT-STZ mice that is reduced in miR-379KO mice. Scale bar, 50 µm. d Representative images of the glomerular basement membrane (GBM) and
podocyte structure using transmission electron microscopy (TEM). Representative TEM images show GBM thickness (Red arrow) and podocyte foot
process effacement in WT-STZ mice, whereas these were not observed in miR-379KO-STZ mice (intact podocyte foot processes, blue arrow). Scale bar,
2 µm. e Quantitative analysis of GBM (n= 64–100 measurements/group). f Excessive mesangial expansion (white arrows) in WT-STZ mice at 24 weeks
after diabetes onset. Scale bar, 0.5 µm. g Representative transmission electron micrographs of mitochondrial structure at 24 weeks after diabetes onset.
Regular internal structure and elongated mitochondria (blue arrow), mitochondrial disrupted cristae (red arrow). h Quantitative analysis of mitochondrial
area in each condition (n= 40 measurement/group). Scale bar, 0.5 µm. Results are expressed as fold over WT-Con. i Representative images show
immunofluorescence staining to detect glomerular p57-positive podocytes (green) and nucleus (blue) at 24 weeks after diabetes onset. Scale bar, 50 µm.
j Quantitative analysis of p57-positive podocytes at 24 weeks after diabetes onset (n= 30 glomeruli/group). Results are expressed as fold over WT-Con.
k IHC staining for p57-positive podocytes (brown). Scale bar, 50 µm. One-way ANOVA with post hoc Tukey’s test for multiple comparisons. *P < 0.05,
**P < 0.01, ***P < 0.001, ****P < 0.0001. All data are presented as mean ± SEM.
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deposits, which was attenuated in miR-379KO-STZ mice at
24 weeks after diabetes onset (Fig. 6f). Our TEM examination also
showed the presence of abnormal mitochondrial structures and
disrupted mitochondrial cristae in the glomeruli of WT-STZ
mice, which were ameliorated in miR-379KO-STZ (Fig. 6g).
Quantitative analysis also showed that the average mitochondrial
area was smaller in WT-STZ mice compared to nondiabetic mice,
but this reduction in area size was not observed in miR-379KO-
STZ relative to corresponding nondiabetic mice (Fig. 6h).
Furthermore, a marker of podocytes (p57) was examined by
immunofluorescence (IF) staining at 24 weeks after diabetes onset
(Fig. 6i). The number of podocytes as detected by nuclear green
fluorescent staining (p57) was lower in WT-STZ mice compared
to WT Control, verifying podocyte loss in diabetic mice.
Quantification of the IF data showed this podocyte loss was
significantly attenuated in miR-379KO-STZ mice (Fig. 6j). IHC
staining of p57 also showed decreased podocyte number in WT-
STZ mice compared to WT-Con, which was reversed in the miR-
379KO mice (Fig. 6k).
Diabetes-induced increase in the expression of Chop and key
cluster miRNAs are reduced in miR-379KO mice. In our pre-
vious study, we found that miR-379 megacluster consists of about
40 other miRNAs besides miR-379, which is the first miRNA
located at the 5′-end of the cluster13. Therefore, to determine
whether loss of miR-379 affects some of the other downstream
miRNAs in this cluster, we used real-time qPCR (RT-qPCR) to
measure their expression in glomeruli isolated from STZ and
control WT and miR-379KO mice. Compared to WT controls, in
the glomeruli of WT-STZ mice, we found significant increases in
the expression of candidate megacluster miRNAs, miR-379, miR-
377, and miR-495. In contrast, these miRNAs were not increased
in the glomeruli of diabetic miR-379KO-STZ mice at 6 (Fig. 7a)
or 24 weeks (Fig. 7b), after the onset of diabetes.
We next examined the expression of Chop, which encodes the
ER stress-responsive CHOP [CCAAT/enhancer-binding protein
(C/EBP) homologous protein] that we previously identified to
control the miR-379 megacluster and its host lncRNA13. We
measured Chop gene expression in glomeruli isolated from STZ-
and control-treated WT and miR-379KO mice. Chop expression
was upregulated in the glomeruli at 1 and 6 weeks after diabetes
onset but returned to normal levels at a later stage (24 weeks)
(Fig. 7c). This diabetes-induced upregulation of Chop was
however attenuated in miR-379KO-STZ compared to WT-STZ
at 6 weeks and was even lower than normal at 24 weeks. This
suggests that deletion of miR-379 may abrogate auto-
upregulation of the miR-379 cluster in a unique fashion through
the EDEM3–ER stress–CHOP axis13.
Diabetes-induced expression of profibrotic genes is reduced in
miR-379KO mice. To determine the role of profibrotic genes in
the observed phenotype of miR-379KO-STZ mice showing pro-
tection from fibrosis and ECM accumulation, we next used RT-
qPCR to measure the expression of Tgf-β1, collagens (Col1α2 and
Col4α1), connective tissue growth factor (Ctgf), and fibronectin
(Fn1) in glomeruli isolated from STZ- and control-treated WT
and miR-379KO mice. As expected, in WT-STZ mice, diabetes
increased the expression of these profibrotic genes at 1, 6, and
24 weeks (Fig. 7d–f) after diabetes onset. This upregulation
was significantly attenuated in miR-379KO-STZ mice at these
time points (Fig. 7d–f). These results suggest that the genetic
deletion of miR-379 attenuates glomerular fibrosis and ECM
accumulation due to downregulation of key profibrotic genes in
diabetic mice.
Diabetes-induced reduction in the expression of miR-379 tar-
get genes is restored in miR-379KO mice. To determine putative
connections between the key identified candidate miR-379 target
genes and the phenotypes/gene expression seen in vivo in the
diabetic miR-379KO-STZ mice, we used RT-qPCR to measure
the expression of miR-379 target genes in glomeruli isolated from
STZ- and control WT and miR-379KO mice. Edem3 gene
expression was significantly decreased in WT-STZ mice, but
restored in miR-379KO-STZ mice, compared to their respective
nondiabetic controls at 6 and 24 weeks after diabetes onset
(Fig. 7g). These results are consistent with our previously pub-
lished results, which showed decreased Edem3 gene expression in
STZ-induced and db/db diabetic mice13. In the current study, we
identified Fis1 and Txn1 as new targets of miR-379. The
expressions of both Fis1 and Txn1 were significantly decreased in
WT-STZ mice, but not in miR-379KO-STZ mice, compared to
their respective nondiabetic controls at 6 and 24 weeks after
diabetes (for Fis1) and at 1 week post diabetes for Txn1 (Fig. 7h,
i). In general, the alterations in the levels of these targets were
relatively mild and not statistically significant at some time
points, likely because the glomeruli are heterogenous and include
other cell types, such as podocytes and endothelial cells, besides
mesangial cells.
To verify that the differential gene expression is accompanied
by differential protein expression of these miR-379 targets in the
glomerular compartments, we used IHC. We stained kidney
cortex sections isolated from STZ- and control WT and miR-
379KO mice with respective antibodies to detect EDEM3, FIS1,
and TXN1 at 6 and 24 weeks after diabetes onset (Fig. 8). The
average EDEM3-positive glomerular area was significantly
smaller in WT-STZ mice compared to nondiabetic controls; this
decrease was reversed in miR-379KO-STZ mice (Fig. 8a, b). FIS1-
positive glomerular area also showed a significant decrease in
WT-STZ mice, which was attenuated in miR-379KO-STZ mice
(Fig. 8c, d). TXN1 staining was weaker in both the cytoplasm and
nucleus in glomeruli of WT-STZ mice compared to WT
nondiabetic mice, but significantly higher in miR-379KO-STZ
than WT-STZ mice (Fig. 8e, f).
To further evaluate relations to mitochondrial function and
biogenesis, we measured glomeruli peroxisomal proliferator-g
coactivator-1a (PGC-1a) expression using IHC staining. PGC-1a
is a major regulator or mitochondrial function and biogenesis. The
results showed a significant decrease in glomerular PGC-1a levels in
WT-STZ mice compared to nondiabetic controls. This reduction
was significantly reversed in miR-379KO-STZ mice (Fig. 8g, h).
As we focused mainly on changes in glomeruli in vivo and in
mesangial cells in vitro, to verify the above observed changes in
these cells, we isolated MMC from the kidney glomeruli of
normal mice and treated them with NG or HG as described in the
“Methods” section. Then, cells were fixed and stained by IF with
antibodies to EDEM3 and FIS1. Results from IF staining
confirmed decreased expression of EDEM3 and FIS1 in the
WT-MMC treated with HG vs. NG, but this decrease was clearly
attenuated in miR-379KO-MMC. Notably, basal EDEM3 levels in
miR-379KO MMC were significantly higher than WT MMC in
NG conditions (Supplementary Fig. 7a–d).
To rule out the background and reveal nonspecific binding,
normal kidney cortex sections were stained without primary
antibodies for EDEM3, FIS1, TXN1, and PGC-1. No significant
staining was detected without primary antibody (Supplementary
Fig. 8).
Taken together, all these results indicate that deletion of miR-
379 in mice plays a significant role in protecting renal glomerular
cells (and possibly tubular cells) from mitochondrial dysfunction,
ER and oxidative stress, and also in attenuating key features DKD
progression, as well as weight loss in STZ-injected diabetic mice.
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Discussion
miR-379 is the most upstream miRNA in the miR-379 mega-
cluster of miRNAs hosted by the lncRNA, lncMGC, which plays a
role in early DKD13. In this study, we examined the in vivo role of
miR-379 in the pathogenesis of DKD by studying the phenotype
of miR-379KO mice, which we created using CRISPR-Cas9
editing. Although miR-379KO mice showed no apparent defects
or detectable phenotypes under normal conditions, however,
when rendered diabetic, they depicted protection from features of
DKD, including albuminuria, glomerular hypertrophy, and
fibrosis. It is interesting that the miR-379KO mice exhibited
phenotypic variation only in response to a challenge (diabetes in
this setting). This has also been seen in other single miRNA KO
mice31,32, which may be because deletion of one miRNA does not
critically affect embryonic or tissue development (due to com-
pensation by other miRNAs/processes) but is however important
for kidney disease progression likely due to functions of critical
targets of the specific miRNA (miR-379).
Using an AGO2-CLASH strategy in MMC from WT and miR-
379KO mice, we identified several new targets of miR-379, while
also confirming a previously identified target, Edem313. We
observed that the levels of key targets of miR-379 such as Edem3,
Fis1, and Txn1 were significantly reduced in WT diabetic mice
compared to nondiabetic mice. However, their levels were
restored in miR-379KO diabetic mice. EDEM3 is implicated in
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Fig. 7 Glomerular expression of cluster miRNAs, profibrotic genes, and miR-379 target genes in WT and miR-379KO mice. a, b Expression of indicated
miRNAs (miRs) in control and STZ-treated WT and miR-379KO mice at a, 6 and b, 24 weeks after diabetes onset (n= 4–6/group). c Expression of
glomerular Chop, an ER stress-responsive transcription factor (n= 5–8/group, n= 6–8/group, and n= 5–6/group for 1, 6, and 24 weeks of diabetes,
respectively). Results are expressed as fold over WT-Con, after normalization with internal control U6. d–f Glomerular expression of profibrotic genes, Tgf-
β1, Col1a2, Col4a1, Ctgf, and Fn1 at 1, 6, and 24 weeks (d–f) after diabetes onset (n= 5–8/group, n= 5–8/group, and n= 5–6/group for 1, 6, and 24 weeks of
diabetes, respectively). g–i Glomerular expression of miR-379 target genes. g Edem3, h Fis1, and i Txn1 were measured in WT and miR-379KO mice (n=
5–8/group, n= 6–8/group, and n= 5–6/group at 1, 6, and 24 weeks of diabetes, respectively). Results are expressed as fold over WT-Con, after
normalization with internal control Cypa. Each dot indicates the value from each mouse. Statistical analyses were performed by one-way ANOVA with post
hoc Tukey’s test for multiple comparisons. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. All data are presented as mean ± SEM.
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mitophagy to preserve mitochondrial health22, whereas TXN1 is a
known antioxidant26,33, which binds to and inactivates
thioredoxin-interacting protein (TXNIP), a potent pro-oxidant.
Thus, miR-379-mediated downregulation of these protective
factors could be a mechanism by which miR-379KO mice are
protected from DKD induced by ER stress, mitochondrial dys-
function, and oxidant stress (Fig. 9). These results are consistent
with our previous report demonstrating that inhibition of
lncMGC (host RNA of the miR-379 megacluster) by GapmeR
antisense oligos reduced the expression of miR-379 and protected
mice from early features of DKD through prevention of ER
stress13. Our current study provides unequivocal evidence for the
pathological role of endogenous miR-379. Importantly, we also
demonstrate how miR-379 may mediate a pro-DKD phenotype
by directly targeting genes such as Fis1, Txn1 and Edem3.
We also mined the Nephroseq database (https://www.
nephroseq.org) for the expression in human samples of miR-
379 target genes identified from our CLASH profiling. Intrigu-
ingly we found that expressions of EDEM3, FIS1, and TXN1, as
well as other candidate targets are significantly decreased in
kidney samples from human subjects with diabetic and chronic
kidney disease as well as other kidney diseases (Supplementary
Figs. 9 and 10), suggesting that our results in diabetic mice are
relevant to human chronic kidney disease.
Notably, our data suggests a protective role for FIS1 in DKD
for the first time. FIS1 is involved in quality control of mito-
chondria via adaptive mitophagy pathways, in which FIS1
interacts with autophagy protein syntaxin17 to trigger mito-
phagy25. FIS1 displays different roles depending on which





















































































b                            WT miR-379KO
Control ControlSTZ STZ





















c                            
d                            
e                            
f                            
g                            







































































Fig. 8 Immunohistochemical staining and quantitative analysis of miR-379 target proteins. a, b EDEM3 (n= 32 and 50 glomeruli/group for 6 and
24 weeks, respectively), c, d FIS1 (n= 50 glomeruli/group), e, f TXN1 (n= 30 and 50 glomeruli/group for 6 and 24 weeks, respectively), and g, h PGC-1a
(n= 50 glomeruli/group) protein in kidney cortex sections from WT and miR-379KO mice at 6 and 24 weeks after diabetes onset. Scale bar, 50 µm. Bar
graph results are expressed as fold over WT-Con. Statistical analyses were performed by one-way ANOVA with post hoc Tukey’s test for multiple
comparisons. *P < 0.05, **P < 0.01, ****P < 0.0001. All data are presented as mean ± SEM.
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triggers mitophagy24 and mutation of Fis1 disrupts mitophagy
needed for elimination of damaged and dispensable mitochon-
dria23 following cellular stress21,34. These results are consistent
with our observations showing decreased expression of FIS1 in
WT diabetic mice (and with HG) in parallel with impaired
mitochondria quality. As autophagy is decreased in the diabetic
kidneys35–38, mitochondrial dysfunction may be accelerated due
to impaired clearance of damaged mitochondria as a result of
reduced autophagy/mitophagy.
We also found that mitochondrial biogenesis, as assessed by
TEM and expression of PGC-1α as surrogate marker, was
impaired in the glomeruli of diabetic WT mice, but not in dia-
betic miR-379KO mice. PGC-1, a master transcriptional regulator
of mitochondrial biogenesis and function, is decreased in diabetic
kidneys39. Overexpression of PGC-1 can protect kidney fibrosis
in chronic kidney disease40 and reduce oxidative stress in kidney
cells in DKD41,42. We also observed that mitochondria-related
genes were differentially enriched between WT and miR-379KO
MMC. Furthermore, using Seahorse metabolic profiling, we
observed a significant decrease in mitochondrial activity in WT
MMC treated with HG, whereas miR-379KO MMC maintained
higher mitochondrial activity even after HG treatment.
Mitochondrial quality and function are impaired in diabetic
conditions, leading to increased generation of reactive oxygen
species and oxidant stress associated with DKD6,43,44. TXN1 is a
small multifunctional protein with oxidoreductase activity26. The
antioxidant function of TXNIP is compromised by interaction
with TXNIP and overexpression of TXN1 suppresses DKD in
transgenic mice45. Our results showing lower expression of Txn1
in the glomeruli of WT diabetic mice may be associated with
increase in oxidant stress coupled with inflammation and upre-
gulation of Tgf-β1 in DKD, events that are reversed in miR-379KO
mice. It is well-known that levels of TGF-β1, a master regulator of
fibrosis, are increased in most renal cells in diabetes1–5. We also
observed that increased expression of Tgf-β1, as well as other
profibrotic genes such as Col1αa2, Col4a1, Ctgf and Fn1 was
attenuated in glomeruli from diabetic miR-379KO mice compared
to diabetic WT mice. Diabetic conditions associated with
increased Tgf-β1 upregulate the expression of several miR-379
cluster miRNAs besides miR-379, as well as Chop, the gene
encoding a well-known ER stress transcription factor46 and we
found these factors are reduced in miR-379KO mice. These data
suggest a feedback amplification loop, because our previous report
showed CHOP upregulates the miR-379 cluster expression
through XBP-1 splicing activation and reduction in ATF3
expression3,13. Of interest, we observed that, besides miR-379,
other members of the miR-379 cluster showed lower expression in
diabetic miR-379KO mice compared to WT mice. Genetic dele-
tion of miR-379 may diminish such auto-upregulation of
lncMGC, as well as the miR-379 cluster, thereby suppressing the
expression of other members of the miR-379 cluster under dia-
betic conditions. miR-379KO mice are deficient in miR-379;
therefore, they can be protected even in diabetic conditions,
because miR-379 is not upregulated, and its targets (such as Fis1,
Edem3, and Txn1) are not downregulated (or possibly even
increased in the kidneys of miR-379KO mice).
Histological and TEM analyses showed that ECM accumula-
tion, fibrosis, podocyte injury and loss, GBM thickness, and
glomerular hypertrophy were all clearly reduced in diabetic miR-
379KO compared to diabetic WT mice. Similar protection was
previously observed in diabetic mice injected with a GapmeR
targeting lncMGC13. Thus, our current study suggests that, in
addition to ER stress regulated by the miR-379 target Edem3,
mitochondrial dysfunction and oxidant stress regulated by the
miR-379 targets Fis1 and Txn1 are also major players in DKD
development (Fig. 9).
We also observed that WT diabetic mice depicted significant
weight loss, which was not observed in miR-379KO. Body com-
position results suggest that recovery of lean mass in diabetic
miR-379KO mice is the main reason for attenuated body weight
loss, suggesting that mitochondrial dysfunction through miR-
379-mediated decrease in Fis1 levels may be involved in muscle
loss in WT diabetic mice but not in miR-379KO mice due, at least
in part, to restoration of Fis1 levels. Future studies are however
needed to systematically examine the role of miR-379 in skeletal
muscle functions and parameters of atrophy in these mice.
As miR-379KO mice did not depict any overt defects or
abnormal phenotypes under normal unchallenged conditions,
inhibiting or reducing miR-379 is likely safe under normal
healthy conditions. Under diabetic conditions, however, miR-
379KO mice were protected from features of DKD. Thus, low-
ering miR-379 by targeting it directly, or its host lncMGC (with
GapmeRs), could be an effective modality to slow down the
progression of DKD.
Methods
Generation of miR-379KO mice. All animal studies were conducted according to
protocols approved by the Institutional Animal Care and Use Committee at the
Beckman Research Institute of City of Hope. Plasmids PX461 (enhanced GFP,
EGFP) and PX462 (Puromycin)15 for gene editing with the CRISPR-Cas9 nickase
strategy were obtained from Addgene. pSpCas9n(BB)-2A-GFP (PX461) were
a gift from Feng Zhang, Broad Institute through Addgene (plasmid #48140;
http://n2t.net/addgene:48140; RRID:Addgene;48140). pSpCas9n(BB)-2A-Puro
(PX462) V2.0 was a gift from Dr. Feng Zhang (Addgene plasmid #62987;








ER stress Adaptive 
mitophagy
Oxidative stress
Accumulation of damaged Mitochondria
Col41, Col21, Ctgf, Fn1 Glomerular damage
ECM accumulation, fibrosis




Fig. 9 Proposed model illustrating the role of miR-379 in promoting early
features of kidney disease in diabetic mice. Diabetic conditions induce
expression of the miR-379 cluster via TGF-β signaling. This increase
includes upregulation of miR-379 and subsequent downregulation of its
targets (Edem3, Fis1, Txn1) related to ER stress, adaptive mitophagy,
mitochondrial dysfunction, and oxidant stress, which are directly involved in
the development of early features of DKD, such as ECM accumulation,
glomerular hypertrophy, and fibrosis. Activated ER stress can also increase
CHOP transcription factor and the miR-379 cluster miRNAs, creating a
positive feedback. Genetic deletion of miR-379 can diminish these
alterations induced by diabetes, interrupt the auto-feedback, and protect
against DKD progression.
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http://n2t.net/addgene:62987:62987; RRID:Addgene_62987). Double-stranded
DNAs obtained by annealing of sense and antisense oligos (Supplementary
Table 3) were cloned into BbsI-digested vectors47. Potential target sites (Supple-
mentary Table 3) were designed using the online software CRISPRdirect48. For T7
in vitro transcription, we found that the pair of S2 and AS1 oligos (out of all pairs
of S1, S2, or S3 and AS1 or AS2) worked best for in vitro screening (verified by
deletion of miR-379 region by PCR, and reduction of miR-379 expression by RT-
qPCR) using Transformed C3H Mouse Kidney-1 (TCMK1) cells,TCMK1 (ATCC,
CCL-139). T7 priming site-tagged PCR fragments were amplified from the plas-
mids using primers T7S2 5′-TTAATACGACTCACTATAGGGATGGTAGACTA
TGGAACGT-3′, T7AS1 5′-TAATACGACTCACTATAGGGTTAGTGGACCATG
TTACAT-3′, and guide RNA-R 5′-AAAGCACCGACTCGGTGCC-3′.
Amplified PCR fragments were used as templates for in vitro transcription
using a T7 in vitro transcription kit (MEGAscript TM T7 Transcription Kit,
Ambion). In vitro transcribed RNAs were purified using MEGAclear™
Transcription Clean-Up Kit (Ambion). Guide RNAs and Cas9 nickase RNA
(TriLink BioTechnologies) were injected into fertilized eggs from female C57BL/6J
mice to produce mutant mice. A mixture of S1 sgRNAs, AS2 sgRNAs (50 ng/μl
total) and 50 ng/μl Cas9 nickase mRNA was microinjected into the cytoplasm of
fertilized C57BL/6J 1-cell embryos using standard methods and these embryos
were implanted surgically into pseudo-pregnant recipient female mice to produce
mutant mice.
Mutant candidate mice were screened for the anticipated 36 bp deletion by
performing PCR with DNA extracted from the tails of surviving mice. Several
founders had shorter fragments relative to WT by fragment analysis49 and the
deletion was confirmed by sequencing (Fig. 1b). Founders confirmed to have the
anticipated 36-bp deletion were crossed with WT C57BL/6 mice and subsequent
litters tested for germline transmission of the miR-379 deletion. Heterozygotes
were crossed with each other to obtain homozygotes. Significant decrease of miR-
379 expression was confirmed using qPCR in miR-379KO mice.
Mouse models of diabetes. Diabetes was induced by injecting 50 mg/kg STZ
intraperitoneally daily for 5 consecutive days in 10-week-old male WT (WT-STZ)
and miR-379KO (miR-379KO-STZ) C57BL/6 mice in accordance with the Dia-
betes Complications Consortium (https://www.diacomp.org/). Male mice injected
with diluent (citrate buffer pH 4.0) served as controls (WT-Con and miR-379KO-
Con). Diabetes was confirmed by measuring tail vein blood glucose levels (fasting
glucose > 300 mg/dl). As, unlike male mice, STZ-injected female mice of the same
age did not develop high blood glucose levels, female mice were not evaluated in
this study. Each experimental group was composed of five to eight mice. Mice were
killed at 1, 6, and 24 weeks post-induction of diabetes. After killing, blood was
taken from the heart for serum collection, and kidneys were harvested for isolation
of glomeruli, preparation of MMC, and histopathological examination (Supple-
mentary Fig. 5).
Isolation of mouse glomeruli and preparation of primary MMCs. Glomeruli
were isolated from freshly harvested mouse kidneys using an established sieving
technique13. Briefly, renal capsules were removed, and the cortical tissue of each
kidney was separated by dissection. The cortical tissue was then carefully strained
through a stainless sieve with a pore size of 200 μm by applying gentle pressure.
Enriched glomerular tissue below the sieve was collected and transferred to another
sieve with a pore size of 150 μm and then 75 μm. After several washes with cold
PBS, the glomeruli remaining on top of the sieve were collected. Pooled glomeruli
were centrifuged and the pellet was collected for RNA, protein extraction, or for
preparing MMC according to our reported methods13. MMC were maintained in
Roswell Park Memorial Institute medium 1640 medium supplemented with 10%
fetal bovine serum. Passages 5–7 were used for experiments13.
RNA sequencing. Total RNA was subjected to library preparation using the KAPA
Stranded mRNA-Seq Kit (KK8421; Kapa Biosystems) followed by cluster genera-
tion and sequencing performed on HiSeq 2500 platform with 51 bp single-end
reads or 101 bp paired-end reads at City of Hope’s Integrative Genomics Core.
RNA-seq data analysis. Raw sequences were aligned to the mouse reference
genome mm10 using TopHat v2.0.1450 with default parameters, and gene-level
expression levels of all the mouse RefSeq genes (downloaded from USCS genome
Browser, https://genome.ucsc.edu) were counted using htseq-count51 v 0.6.0 with
settings -s reverse (strand-specific) and -a 10 (filtrating poor alignment reads). The
counts were normalized by trimmed mean of M value (TMM) method52 and
differentially expressed genes between groups were identified using Bioconductor
package edgeR53 (fold change > 1.5 and P < 0.05). IPA was applied to differentially
expressed genes for gene ontology and pathway analyses.
AGO2-CLASH technique. CLASH procedures were performed according to
published methods19,20. Briefly, MMC from WT and miR-379KO mice were plated
in four 10 cm petri dishes (70% confluence), washed with PBS, and cross-linked by
exposure to 50 J/m2 UV using a UV Stratalinker (Stratagene). RNA was isolated
using a miRNA Isolation kit (mouse AGO2) obtained from WAKO, Japan (Catalog
number 292-67301). Briefly, cross-linked cells were collected using 200 μl lysis
buffer (provided in the miRNA Isolation kit, WAKO) per dish, gently mixed,
incubated on ice for 10 min, sonicated (30 s × 5 with 30 s intervals) using a
BIORUPTOR (Diagenode), and stored at −80 °C. AGO2 RISC complex was
immunoprecipitated with anti-mouse AGO2 beads (WAKO) by gently rocking at
4 °C and washed with lysis buffer three times. The 5′-ends of RNAs in the
immunoprecipitates were phosphorylated using polynucleotide kinase PNK (New
England BioLabs (NEB), Ipswich, MA) (50 units in 20 μl) at 20 °C for 2 h, washed
with lysis buffer, ligated using T4 RNA ligase (NEB) (50 units in 20 μl) at 16 °C for
16–18 h (overnight), eluted, extracted using phenol-isoamyl alcohol and chloro-
form, precipitated with ethanol, washed with 70% ethanol, air dried, and dissolved
in 10 μl nuclease-free water. Extracted RNAs were subjected to next-generation
RNA-seq or conventional qPCR. To detect enrichment of potential target RNAs in
AGO2 RISC, RNAs extracted without ligation reaction from WT and miR-379-KO
MMC were also sequenced (small RNA-seq) and compared to the enrichment of
RNAs between WT and miR-379-KO MMC.
CLASH sequencing. To detect miRNA–mRNA hybrid reads, libraries were con-
structed based on Illumina’s small RNA-seq protocol as described previously13, but
without size selection. Specifically, 5 μl of crossed-linked RNA was directly ligated
to 3′-adapter (5′-UCUGGAAUUCUCGGGUGCCAAGGAACUCC-3′) followed by
5′-adapter (5′-GUUCAGAGUUCUACAGUCCGACGAUC-3′), reversed-
transcribed to single-stranded cDNA, and amplified by PCR. The constructed
library was then undergone purification, cluster generation and 101 bp paired-end
sequencing on HiSeq 2500 platform by the same core.
CLASH-seq data analysis. Paired-end raw sequenced reads were merged using pear
v0.9.5 with parameters settings -n 30 -p 1.0. Any merged reads aligned to either
mouse whole genome (GRCm38.p5) or RNA transcripts (GENCODE vM13) using
Bowtie2 v2.1.0 with settings -very-sensitive were subsequently removed. The
remaining merged reads were then searched to identify the ones partially aligned to
mature miRNA (miRbase release 21) and/or mRNA sequences (GENCODE vM13)
using blastn program in blastall v2.2.26 with parameters (-e 10 -S 3 -W 7 -m 8 for
miRNA and -e 0.1 -S 3 -W 7 -m 8 for mRNA). Finally, chimeric reads were selected
as the merged reads if (1) they are partially aligned to any mature miRNA and any
mRNA and (2) the aligned regions are not overlapped. The chimeric reads con-
taining partial mature miR-379 sequences were further identified.
AGO2-IP RNA-seq data analysis. For each sample, paired-end 101 bp raw data
were processed using the same approach as done on single-end samples (aligned by
TopHat, counted by HTseq-count, TMM-normalized). Difference on expression
between KO vs. WT samples were performed using simple model in edgeR. To
identify miR-379 targets in mouse, 94 potential targets (genomic locations) on
mm10 predicted by miRanda/mirSVR were first obtained from starBase v2.054
(http://starbase.sysu.edu.cn/starbase2/targetSite.php). The 5′-end of each target was
then extended to 100 bp in width. For each target, read counts located in both the
extended target region (TAR) and non-target 3′-UTR region (NT3UTR) were
summarized using R packages “rtracklayer” and “GenomicRanges”. The local
enrichment of each TAR relative to its own NT3UTR region was calculated using
log2 (TAR/NT3UTR) in each sample. Enrichment level between IPKO (Immuno
Precipitation Knock-Out) and IPWT (Immuno Precipitation Wild-Type) samples
at each target with local enrichment level < 1 was compared and targets were
ranked based on the fold change between KO and WT samples.
miRNA mimics and siRNAs. Oligonucleotide mimics of miRNAs, siRNAs, and
corresponding control oligos were obtained from Integrated DNA Technologies or
Thermo Fisher Scientific, Inc. (Waltham, MA), as described55,56. Briefly, MMC
(~106/transfection) were transfected with siRNA or miRNA oligos using an Amaxa
Nucleofector (Lonza, Basel, Switzerland) according to the manufacturer’s protocols
as described previously55,56. Mouse Fis1 siRNAs (double-stranded oligos were
obtained from Thermo Fisher Scientific, Inc. Non-targeting siRNA controls were
obtained from Thermo Fisher Scientific, Inc. MMC were trypsinized and resus-
pended in Basic Nucleofection Solution at 1 × 107/ml. Subsequently, 100 μl of cell
suspension (1 × 106 cells) was mixed with miRNA mimic, inhibitor oligonucleo-
tides, or ON-TARGET plus siRNA or NCs (Thermo Fischer Scientific, Inc.,
Waltham, MA). Transfected cells were collected for RNA extraction or fixed for
IHC staining. RNA was extracted from the cells and the expression of miRNAs
within the cluster was examined using primers designed for each of the mature
miRNAs (miRBase).
Luciferase reporter assays. Mouse Fis1 3′-UTR and Txn1 3′-UTR regions were
amplified by PCR using the primers shown below (F and R refer to forward and
reverse primers, respectively): mFis1 3UTR F-XhoI 5′-gagctcgAGGCAGCCTCAC
CTGCTCTC-3′, mFis1 3UTR R-NotI 5′-cctgcggccgcACACTCATTGCAAAGCA
TGACAGG-3′; mTxn1-3UTR F-XhoI 5′-TGctcgagTCATGCTCTGAAAAGTGTA
ACCA-3′, mTxn1-3UTR R-NotI 5′-CTgcggccgcTCATTTATATTAAAACACATC
AGGCAG-3′.
Amplified Fis1 3′-UTR and Txn1 3′-UTR were digested with XhoI and NotI,
and then cloned into the NotI-XhoI site of the psiCheck2 vector (Promega). For
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mutagenesis of the miR-379-binding site in Fis1 3′-UTR (designated MT for
mutant), the primers listed below were used.
Mutagenesis primers: mFis1 3UTR MT-F 5′-CACCCCTGTAGgagctCTCTACA
GTCT-3′ and mFis1 3UTR MT-R, 5′-AGACTGTAGAGAGCTCCTACAGGGGT
G-3′, where F and R refer to forward and reverse primers, respectively. Lower cases
are mutated bases.
For mutagenesis of the miR-379-binding site in the Txn 3′-UTR (designated
MT), PCR fragment including deletion of miR-379-binding site was amplified
using primers below and cloned into psiCheck2. mTxn1-3UTR-F-XhoI 5′-
TGctcgagTCATGCTCTGAAAAGTGTAACCA-3′ and mTxn1-3UTR-379del-R-
NotI 5′-CAgcggccgcTTAATATTTTATTGTCATTTATAATCAGATG-3′. Lower
cases are restriction enzyme sites for cloning into plasmid vectors.
MMC were transfected with these reporter plasmids along with miR-379 mimic
or NC oligos (Thermo Fischer Scientific, Inc., Waltham, MA) using an Amaxa
Nucleofector. Luciferase activity was measured and analyzed according to
manufacturer’s protocol, as described previously56.
Real-time qPCR. RT-qPCR analysis was performed as previously described13.
Briefly, RNA was extracted using an RNEASY Mini kit (Qiagen, Valencia, CA).
miRNA quantification was performed using the qScript miRNA cDNA synthesis
kit (Quanta Biosciences, Gaithersburg, MD) and amplified using PerfeCTa SYBR
Green Supermix (Quanta Biosciences). For miRNAs, specific mature miRNA
sequences were used as forward primers and the universal primer provided in the
kit as the reverse primer. U6 was used as an internal control. A GeneAmp RNA
PCR kit (Applied Biosystems, Carlsbad, CA) and POWER SYBR Green mix
(Applied Biosystems) were used for mRNA quantification. mRNA expression
normalized to Cypa as an internal control. PCR primer sequences are shown in
Supplementary Table 4.
Measurement of body composition and metabolic parameters. Whole body
composition (fat and lean tissues) of mice was determined using quantitative
magnetic resonance imaging technology (EchoMRI™ 3-in-1; Echo Medical Systems,
Houston, TX). Automatic tuning and calibration of the instrument parameters
using canola oil maintained at room temperature (22 °C) were performed daily.
One mouse was placed in the analytical chamber at a time. Parameters measured
by the EchoMRI™ included lean mass (g), fat mass (g), free water (g), and total
water (g). Alterations to body composition metabolic parameters such as VO2,
VCO2, RER, food intake, water consumption, and locomotor activity were also
measured using an indirect calorimetry cage system (PhenoMaster, TSE Systems,
Bad Homburg, Germany) located in the City of Hope Comprehensive Metabolic
Phenotyping core.
Mice were weighed and then individually housed in cages for 3 days. Animals
were acclimated to the cages for 1 day and experimental data were collected for 48
h following the acclimation day. Animals were given ad libitum access to food and
water and housed in a temperature-controlled environment with a 12 h light/dark
cycle for the duration of the experiment. The PhenoMaster is an indirect
calorimetry system with gas-sensing units to measure VO2 and VCO2. A multi-
dimensional infrared beam system allows the measurement of locomotor activity,
which was defined as the total number of infrared beam breaks in the X and Y axis.
The software was set to divide the experimental period into 30 min segments.
Metabolic flux assays and mitochondrial respiration assays. OCR and extra-
cellular acidification rate were measured using Agilent Seahorse XF Cell Mito Stress
Test Kit on an XF96 Extracellular Flux Analyzer (Agilent, Santa Clara, California,
USA). MMC were seeded at a density of 6000–8000 cells per well in 96-well plates.
Cells were treated with NG (5.5 mM) and HG (25 mM) for 72 h before switching to
Dulbecco’s modified Eagle’s medium base medium pH 7.4 (supplemented with 10
mM glucose, 1 mM sodium pyruvate, and 2 mM glutamine) on the day of the assay
and incubated at 37 °C for 1 h in a non-CO2 incubator. Mitochondrial function
parameters were determined following serial addition of three mitochondrial
inhibitors, ATP synthase inhibitor oligomycin (2 mM final concentration), proton
carbonyl cyanide p-trifluoromethoxyphenylhydrazone (1.5 mM final concentra-
tion), and a mixture of complex I and III inhibitors, rotenone, and antimycin A,
respectively (0.5 mM each final concentration). Mitochondrial function was
assessed by determining the basal respiration, ATP turnover rate, proton leak, and
maximal and spare respiratory capacity using the mitochondrial inhibitors
described above. OCR was calculated using Seahorse XF96 analyzer software.
Method to assess mitochondrial quality and adaptive mitophagy. For detection
of mitochondria by fluorescence microscopy, WT and miR-379KO MMCs were
transfected with the DsRed2-Mito-7 plasmid (Addgene plasmid# 55838), which
fluorescently labels mitochondria with red emission spectra. For quantification
analysis, all images were captured at ×60 magnification using a Keyence micro-
scope (KEYENCE-BZ-X800 Series, Osaka, Japan) and quantitatively analyzed using
ImageJ software (ImageJ. win32). To measure the mean fluorescence intensity of
labeled mitochondria in each cell, we used a previously published method57,58,
based on integrated density, called “Corrected Total Cell Fluorescence (CTCF).”
This method normalizes the mean intensity of each cell area to the background
using the following formula: CTCF= Integrated Density− (Area of selected cell ×
Mean fluorescence of background readings).
To monitor adaptive mitophagy, MMCs were transfected with pCLBW-cox8-
EGFP-mCherry (also known as addgene #78520)23. WT or miR-379KO MMC
were then incubated in HG (25 mM) or NG conditions at 37 °C and 5% CO2 for
5 days, and the experiments were repeated three times. For live-cell imaging, the
live cells were placed in the environmental chamber of Keyence microscope
(KEYENCE.BZ-X800E), which is maintained at 37 °C and 5% CO2. The 488 nm
and 561 nm were used to excite cox8-EGFP-mCherry. In these experiments, as
described in the “Results,” normal cells with healthy mitochondria expressed yellow
signals (i.e., green plus red fluorescence), whereas mitochondria depicting adaptive
mitophagy showed predominantly red fluorescence, due to the selective sensitivity
of EGFP fluorescence to low pH. All images were captured at ×60 magnification.
The number of mitochondria within each cell was counted using ImageJ software
(ImageJ. win32) and then the percentage of red-only puncta in cells was calculated.
Measurement of urine albumin and creatinine concentration in mice. Albumin
was measured as a marker for kidney damage and dysfunction in 24-h collected
urine samples using an ELISA kit (Crystal Chem#80630). Urine creatinine was
measured using a high-quality enzymatic assay for mouse creatinine (Crystal
Chem#80350). Urine albumin excretion was then normalized to urine creatinine to
obtain ACRs to correct for variations in urine flow rate.
Histology and IHC. Kidney cortex samples were fixed in 10% formalin and pre-
pared for light microscopic examination according to routine histological techni-
ques (Pathology: Solid Tumor Core, City of Hope). The sections were stained with
PAS to identify ECM accumulation and with Masson’s Trichrome for detection of
fibrosis in the glomerular mesangial area. Under light microscopy examination,
glomerular size, mesangial PAS-positive areas, and cortex fibrotic areas were
measured in each group using Image-Pro Premier 9.2 software.
The cellular localization of EDEM3 (1:100, NBP1-88342, Novus Biologicals),
FIS1 (1:250, ab71498, Abcam), TXN1 (1:400, ab86255, Abcam), p57 (1:500,
ab75974, Abcam), PGC-1α (1:300, ab54481, Abcam), ATG5 (1:150, ab108327,
Abcam), and p62 (1:100, ab155686, Abcam) was examined in glomerular sections
using IHC. Biotinylated goat anti-rabbit (1:400, BA-1000, Invitrogen) was used as
secondary antibody. To rule out the background by the secondary antibody, we
performed control staining without primary antibody using normal mouse kidney
sections followed with incubation with Avidin : Biotinylated enzyme Complex
(ABC) system (VECTASTAIN ABC Kits-Vector) and then DAB (Supplementary
Fig. 8). IHC images were taken at ×20 magnification and immune-positive reaction
areas were quantified in the glomeruli in each group using ImageJ software.
IF staining was performed to show the cellular localization of p5759,60, podocyte
marker (1:250, ab75974, Abcam), EDEM3 (1:100, NBP1-88342, Novus Biologicals),
and FIS1 (1:250, ab71498, Abcam), and with the following Alexa Fluor 488, goat
anti-rabbit (1:500, A11034, Invitrogen) secondary antibody. IF images were taken
using original magnification of ×20. p57-positive cells were counted in 30 glomeruli
from each group using BZ-X800 image analyzer (KEYENCE-BZ-X800 Series,
Osaka, Japan). EDEM3- and FIS1-specific fluorescence (integrated density) were
measured (n= 15–20 cell/group) using ImageJ software (ImageJ-Win32) and then
CTCF was calculated as described above.
TEM examination. The cortices of the mouse kidney were fixed in 2.5% v/v
glutaraldehyde solution for 24 h, then processed for TEM examination according to
routine TEM processing and staining protocols for tissues in the City of Hope
Electron Microscopy and Atomic Force Microscopy Core13. Ultra-thin sections
were cut using a Leica Ultra-cut UCT ultramicrotome. TEM was performed on FEI
Tecnai 12 TEM equipped with a Gatan Ultrascan 2 K CCD camera. Average GBM
thickness was quantified in ~100 measurements and area of 40 mitochondrion was
measured in each group using Image-Pro Premier 9.2 software.
Statistics and reproducibility. Statistical data analyses were performed using
GraphPad Prism software (8.2.1). Normal distribution of each sample group was
confirmed using χ2-test or Shapiro–Wilk test before comparison between groups.
All data were expressed as mean ± SEM and statistical analyses were performed
using Student’s t-tests (two-sided) to compare two groups or analysis of variance
followed by post hoc Tukey’s test, to compare multiple groups. For all experiments,
the number of replicates is shown in the figure legends. For experiments with mice,
the number included is also noted in the figure legends. A minimum sample size of
five mice in each group was used based on both our previous experience and power
analyses. We have at least 80% power to detect an effect size of two between WT
and KO groups, or diabetic and nondiabetic groups at a confidence level p < 0.05
using two-sided t-tests. Asterisks indicate significant difference (*p < 0.05, **p <
0.01, ***p < 0.001, and ****p < 0.0001).
Data availability
All sequencing datasets generated in this study have been deposited into GEO with
GEO #s GSE142596, GSE142597, and GSE142598. The source data underlying the
graphs in figures are provided in Supplementary Data 1 and 2. Full gel is shown in
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Supplementary Information. All relevant data are available from the authors upon
request.
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